Vitalhub (TSE:VHI) Director Acquires C$349,500.00 in Stock

Vitalhub Corp. (TSE:VHI) Director Francis Nelson Shen bought 50,000 shares of the stock in a transaction dated Thursday, March 26th. The stock was bought at an average price of C$6.99 per share, with a total value of C$349,500.00. Following the acquisition, the director owned 50,000 shares in the company, valued at approximately C$349,500. This represents a ∞ increase in their position.

Francis Nelson Shen also recently made the following trade(s):

• On Tuesday, March 24th, Francis Nelson Shen bought 439,600 shares of Vitalhub stock. The stock was bought at an average cost of C$7.00 per share, for a total transaction of C$3,077,200.00.

Vitalhub Price Performance

Shares of TSE:VHI opened at C$6.95 on Monday. The company’s fifty day moving average price is C$8.07 and its 200 day moving average price is C$9.29. Vitalhub Corp. has a 12 month low of C$6.67 and a 12 month high of C$14.64. The firm has a market capitalization of C$439.46 million, a P/E ratio of 69.50, a P/E/G ratio of 1.18 and a beta of 0.65.

Vitalhub (TSE:VHI) last announced its quarterly earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share for the quarter. The firm had revenue of C$31.39 million during the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. On average, sell-side analysts anticipate that Vitalhub Corp. will post 0.2296467 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on VHI shares. Raymond James Financial dropped their price target on Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Royal Bank Of Canada reduced their price objective on Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research note on Monday, January 26th. Scotiabank decreased their price objective on Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a report on Wednesday, February 4th. Finally, ATB Cormark Capital Markets cut their target price on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of C$13.86.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.